Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The drug candidate acts as an agonist of the glucagon-like peptide-1 (GLP-1) receptor, following the same mode of action as Mounjaro (tirzepatide), the companys peptide-based GLP-1 drug for weight loss
Market players are capitalizing on these opportunities, developing drugs with better efficacy and fewer side effects
To date, GLP-1 therapies have largely been limited to injectable or oral peptide formulations, each with inherent delivery and dosing constraints
Tepmongkol et al., 2008) was reported in a phase II clinical trial that on the other hand concluded a not complete response of patients (Eisenhauer et al., 2009
Level T | Business Hours: | Monday Thursday: 8:00 AM 5:00 PM | Friday: 8:00 AM 12:00 PM | Saturday Sunday: Closed Frequently Asked Questions Yes
By leveraging the bodys natural GLP-1 responses, we can offer innovative treatments that help improve overall health and quality of life
US$ 20.62
US$ 20.38
US$ 21.64
US$ 20.66
US$ 26.40
